{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:12:54Z","timestamp":1785510774754,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biopha.2021.112256","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T02:19:01Z","timestamp":1633141141000},"page":"112256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice"],"prefix":"10.1016","volume":"144","author":[{"given":"Yifang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlan","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad R.S.","family":"Broughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Ferens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Widdop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon D.","family":"Ricardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrishan S.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112256_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2021.112256_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrneph.2016.163","article-title":"The global burden of chronic kidney disease: estimates, variability and pitfalls","volume":"13","author":"Glassock","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2021.112256_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MNH.0000000000000605","article-title":"Acute kidney injury and maladaptive tubular repair leading to renal fibrosis","volume":"29","author":"Yu","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2021.112256_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.ackd.2016.11.002","article-title":"Treatment of renal fibrosis\u2013turning challenges into opportunities","volume":"24","author":"Klinkhammer","year":"2017","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.biopha.2021.112256_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1797.2011.01501.x","article-title":"Mesenchymal stem cells in kidney inflammation and repair","volume":"17","author":"Wise","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.biopha.2021.112256_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4798639","article-title":"Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence","volume":"2016","author":"Peired","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.biopha.2021.112256_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/icb.2012.56","article-title":"Mechanisms of mesenchymal stromal cell immunomodulation","volume":"91","author":"English","year":"2013","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.biopha.2021.112256_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/gfr267","article-title":"Uremia induces functional incompetence of bone marrow-derived stromal cells","volume":"27","author":"Noh","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2021.112256_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.kint.2015.11.023","article-title":"Challenges and opportunities for stem cell therapy in patients with chronic kidney disease","volume":"89","author":"Hickson","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2021.112256_bib10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1089\/hum.2010.165","article-title":"Genetic engineering of mesenchymal stem cells and its application in human disease therapy","volume":"21","author":"Hodgkinson","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biopha.2021.112256_bib11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1096\/fj.14-254789","article-title":"Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy","volume":"29","author":"Huuskes","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2021.112256_bib12","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1210\/en.2010-0286","article-title":"Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis","volume":"151","author":"Hewitson","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2021.112256_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fphar.2016.00195","article-title":"Involvement of cyclic guanosine monophosphate-dependent protein kinase I in renal antifibrotic effects of serelaxin","volume":"7","author":"Wetzl","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112256_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.HYP.0000171930.00697.2f","article-title":"Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats","volume":"46","author":"Lekgabe","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2021.112256_bib15","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1681\/ASN.2005121307","article-title":"Relaxin improves renal function and histology in aging Munich Wistar rats","volume":"17","author":"Danielson","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2021.112256_bib16","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/nau.23721","article-title":"Relaxin-2 therapy reverses radiation-induced fibrosis and restores bladder function in mice","volume":"37","author":"Ikeda","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.biopha.2021.112256_bib17","doi-asserted-by":"crossref","first-page":"R559","DOI":"10.1152\/ajpregu.00528.2012","article-title":"The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease","volume":"305","author":"Sasser","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.biopha.2021.112256_bib18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bph.13529","article-title":"Anti-fibrotic actions of relaxin","volume":"174","author":"Samuel","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112256_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mce.2018.12.016","article-title":"Cardioprotective effects of relaxin","volume":"487","author":"Martin","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2021.112256_bib20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/bph.15361","article-title":"Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K\/DOCA\/salt-induced hypertension","volume":"178","author":"Li","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112256_bib21","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","article-title":"Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms","volume":"289","author":"T\u00f6gel","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2021.112256_bib22","doi-asserted-by":"crossref","first-page":"F1222","DOI":"10.1152\/ajprenal.00675.2013","article-title":"Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury","volume":"306","author":"Wise","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2021.112256_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13287-017-0727-7","article-title":"Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges","volume":"8","author":"Nargesi","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2021.112256_bib24","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.mayocp.2018.12.024","article-title":"Influence of sex on the progression of chronic kidney disease","volume":"94","author":"Neugarten","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biopha.2021.112256_bib25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/bph.13230","article-title":"Inflammasome activity is essential for one kidney\/deoxycorticosterone acetate\/salt-induced hypertension in mice","volume":"173","author":"Krishnan","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112256_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1523-1755.2003.00707.x","article-title":"Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity","volume":"63","author":"Feria","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2021.112256_bib27","doi-asserted-by":"crossref","first-page":"22519","DOI":"10.1038\/srep22519","article-title":"Cells release subpopulations of exosomes with distinct molecular and biological properties","volume":"6","author":"Willms","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112256_bib28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ajpath.2011.05.037","article-title":"Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses","volume":"179","author":"Alikhan","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2021.112256_bib29","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/01.ASN.0000128219.65330.EA","article-title":"Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat","volume":"15","author":"Maric","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2021.112256_bib30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0076-6879(95)48033-1","article-title":"Quantification of matrix metalloproteinases in tissue samples","volume":"248","author":"Woessner","year":"1995","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.biopha.2021.112256_bib31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ndt\/gfi303","article-title":"In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent","volume":"21","author":"Ishola","year":"2006","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2021.112256_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/872827","article-title":"Establishing standards for studying renal function in mice through measurements of body size-adjusted creatinine and urea levels","volume":"2014","author":"Rodrigues","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2021.112256_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/cvr\/cvy252","article-title":"Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension","volume":"115","author":"Krishnan","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2021.112256_bib34","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1172\/JCI90699","article-title":"TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies","volume":"127","author":"McGeough","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2021.112256_bib35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.semnephrol.2007.02.006","article-title":"Matrix metalloproteinases in kidney disease progression and repair: a case of flipping the coin","volume":"27","author":"Ronco","year":"2007","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.biopha.2021.112256_bib36","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1074\/jbc.270.11.5872","article-title":"Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3\/4- and 1\/4-length fragments","volume":"270","author":"Aimes","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.112256_bib37","doi-asserted-by":"crossref","first-page":"F1054","DOI":"10.1152\/ajprenal.00555.2015","article-title":"Spontaneous one-kidney rats are more susceptible to develop hypertension by DOCA-NaCl and subsequent kidney injury compared with uninephrectomized rats","volume":"310","author":"Wang","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2021.112256_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11906-017-0731-4","article-title":"DOCA-salt hypertension: an update","volume":"19","author":"Basting","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.biopha.2021.112256_bib39","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1038\/s41598-017-09470-0","article-title":"Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112256_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/HYPERTENSIONAHA.110.164392","article-title":"Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(\u03c9)-nitro-L-arginine methyl ester hypertensive rats","volume":"58","author":"Sasser","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2021.112256_bib41","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/ndt\/gfr618","article-title":"Relaxin ameliorates salt-sensitive hypertension and renal fibrosis","volume":"27","author":"Yoshida","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biopha.2021.112256_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCRESAHA.113.301646","article-title":"Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts","volume":"113","author":"Parikh","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2021.112256_bib43","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.ajpath.2018.04.013","article-title":"Innate immune cells are regulated by Axl in hypertensive kidney","volume":"188","author":"Batchu","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2021.112256_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2478\/s11658-012-0036-1","article-title":"Mesenchymal stem cells promote a primitive phenotype CD34+c-kit+ in human cord blood-derived hematopoietic stem cells during ex vivo expansion","volume":"18","author":"Rodr\u00edguez-Pardo","year":"2013","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.biopha.2021.112256_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007004.pub3","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease","author":"Bolignano","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2021.112256_bib46","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.HYP.0000145180.38707.84","article-title":"Pathophysiology of hypertensive renal damage: implications for therapy","volume":"44","author":"Bidani","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2021.112256_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of hypertension in chronic kidney disease","volume":"79","author":"Pugh","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2021.112256_bib48","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.transproceed.2009.01.072","article-title":"Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model","volume":"41","author":"Cavaglieri","year":"2009","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.biopha.2021.112256_bib49","doi-asserted-by":"crossref","first-page":"78464","DOI":"10.1371\/journal.pone.0078464","article-title":"Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture","volume":"8","author":"Oliveira-Sales","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2021.112256_bib50","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Prospective studies collaboration, age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.112256_bib51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"Br. Med. J."},{"key":"10.1016\/j.biopha.2021.112256_bib52","doi-asserted-by":"crossref","first-page":"H906","DOI":"10.1152\/ajpheart.00821.2014","article-title":"M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure","volume":"309","author":"Moore","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2021.112256_bib53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/HYPERTENSIONAHA.113.02191","article-title":"PhysGen knockout program, CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney","volume":"63","author":"Rudemiller","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2021.112256_bib54","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/HYPERTENSIONAHA.117.09456","article-title":"Inhibition of mammalian target of rapamycin complex 1 attenuates salt-induced hypertension and kidney injury in Dahl salt-sensitive rats","volume":"70","author":"Kumar","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2021.112256_bib55","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1096\/fj.15-271734","article-title":"Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice","volume":"29","author":"Kadoya","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2021.112256_bib56","doi-asserted-by":"crossref","first-page":"14717","DOI":"10.1096\/fj.201901079RR","article-title":"Serelaxin inhibits the profibrotic TGF-\u03b21\/IL-1\u03b2 axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts","volume":"33","author":"Tapia C\u00e1ceres","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2021.112256_bib57","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3389\/fphar.2020.01201","article-title":"Relaxin can mediate its anti-fibrotic effects by targeting the myofibroblast NLRP3 inflammasome at the level of caspase-1","volume":"11","author":"Pinar","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112256_bib58","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00424-017-1950-x","article-title":"The role of macrophages in hypertension and its complications","volume":"469","author":"Rucker","year":"2017","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.biopha.2021.112256_bib59","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.115.05779","article-title":"Obligatory role for B cells in the development of angiotensin II-dependent hypertension","author":"Chan","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2021.112256_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1523-1755.2005.00386.x","article-title":"Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change","volume":"68","author":"Kuusniemi","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2021.112256_bib61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.scr.2015.09.007","article-title":"Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease","volume":"15","author":"Royce","year":"2015","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.biopha.2021.112256_bib62","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/bph.13494","article-title":"Combining an epithelial repair factor and antifibrotic with a corticosteroid offers optimal treatment for allergic airways disease","volume":"173","author":"Patel","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112256_bib63","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1096\/fj.201802307R","article-title":"iPSC- and mesenchymoangioblast-derived mesenchy-mal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid","volume":"33","author":"Royce","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2021.112256_bib64","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/sctm.19-0044","article-title":"Challenges in clinical development of mesenchymal stromal\/stem cells: concise review","volume":"8","author":"Mastrolia","year":"2019","journal-title":"Stem Cells Transl. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:26:22Z","timestamp":1760099182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221010404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":64,"alternative-id":["S0753332221010404"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112256","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112256"}}